BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Clinical trial NCT02933320 · COMPLETED
Trial details
- NCT number
- NCT02933320
- Sponsor
- Cancer Research UK
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2020-03-19
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.